5a13be122b
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
5.4 KiB
5.4 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Drugs, Prescription - As enacted, requires the commissioners of health and mental health and substance abuse services to produce guidelines on nonresidential buprenorphine treatment by January 1, 2018, and to annually update those guidelines. - Amends TCA Title 63, Chapter 1. | Drugs, Prescription - As enacted, requires the commissioners of health and mental health and substance abuse services to produce guidelines on nonresidential buprenorphine treatment by January 1, 2018, and to annually update those guidelines. - Amends TCA Title 63, Chapter 1. | us/states/tn | Tennessee General Assembly | 110 | SB 709 | Tennessee SB 709 (110) |
|
|
enacted |
|
1 | 45 | 4 | 2017-02-08 | 2017-04-19 | openstates | ocd-bill/1c90b52e-ae2e-433b-85a8-807236eae63d | http://wapp.capitol.tn.gov/apps/BillInfo/default.aspx?BillNumber=SB0709&GA=110 | 053dfd143c0fce9b155de154c202c6d9afc4b7429070b09f2ef8b8533cdc541a | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Tennessee SB 709 (110) — Drugs, Prescription - As enacted, requires the commissioners of health and mental health and substance abuse services to produce guidelines on nonresidential buprenorphine treatment by January 1, 2018, and to annually update those guidelines. - Amends TCA Title 63, Chapter 1.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Current Version (committee substitute) — source
Votes
- FLOOR VOTE: CONCUR IN HOUSE AMEND# 2 3/27/2017 Passed — 31–0 (pass) · upper
- FLOOR VOTE: AS AMENDED PASSAGE ON THIRD CONSIDERATION 3/20/2017 Passed (1) — 96–0 (pass) · lower
- SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0 3/1/2017 Passed — 9–0 (pass) · upper
- FLOOR VOTE: THIRD CONSIDERATION AMENDED 3/6/2017 Passed (1) — 33–0 (pass) · upper
Sponsors
- Powers — primary (person)
- Yager — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2017-02-08 Filed for introduction
introduction, reading-1 - 2017-02-08 Filed for intro.
introduction, reading-1 - 2017-02-09 Introduced, Passed on First Consideration
introduction - 2017-02-09 Intro., P1C.
introduction - 2017-02-13 Passed on Second Consideration, refer to Senate Health and Welfare Committee
- 2017-02-13 P2C, ref. to Health Committee
referral-committee - 2017-02-14 Assigned to s/c Health Subcommittee
referral-committee - 2017-02-22 Placed on Senate Health and Welfare Committee calendar for 3/1/2017
- 2017-02-22 Sponsor(s) Added.
- 2017-02-22 Placed on s/c cal Health Subcommittee for 3/1/2017
- 2017-02-23 Sponsor(s) Added.
- 2017-02-28 Sponsor(s) Added.
- 2017-03-01 Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
- 2017-03-01 Placed on cal. Health Committee for 3/7/2017
- 2017-03-01 Rec. for pass by s/c ref. to Health Committee
committee-passage-favorable - 2017-03-01 Sponsor(s) Added.
- 2017-03-03 Placed on Senate Regular Calendar calendar for 3/6/2017
- 2017-03-06 Engrossed; ready for transmission to House
- 2017-03-06 Sponsor(s) Added.
- 2017-03-06 Passed Senate as amended, Ayes 33, Nays 0
passage - 2017-03-06 Senate adopted Amendment (Amendment 1 - SA0057)
- 2017-03-07 Action def. in Health Committee to 3/14/2017
- 2017-03-08 Placed on cal. Health Committee for 3/14/2017
- 2017-03-09 Rcvd. from S., held on H. desk.
- 2017-03-13 Sponsor(s) Added.
- 2017-03-14 Rec. for pass if am; ref to Calendar & Rules Committee
committee-passage-favorable - 2017-03-15 Placed on cal. Calendar & Rules Committee for 3/16/2017
- 2017-03-16 H. Placed on Regular Calendar for 3/20/2017
- 2017-03-20 Passed H., as am., Ayes 96, Nays 0, PNV 0
passage - 2017-03-20 H. adopted am. (Amendment 2 - HA0095)
amendment-passage - 2017-03-20 Am. withdrawn. (Amendment 1 - HA0094)
amendment-withdrawal - 2017-03-20 Subst. for comp. HB.
- 2017-03-20 Comp. SB subst.
- 2017-03-20 Sponsor(s) Added.
- 2017-03-24 Placed on Senate Message Calendar calendar for 3/27/2017
- 2017-03-27 Concurred, Ayes 31, Nays 0 (Amendment 2 - HA0095)
passage - 2017-03-28 Signed by Senate Speaker
- 2017-03-28 Enrolled and ready for signatures
- 2017-03-28 Sponsor(s) Added.
- 2017-03-29 Signed by H. Speaker
- 2017-03-30 Transmitted to Governor for action.
- 2017-04-07 Signed by Governor.
executive-signature - 2017-04-19 Pub. Ch. 112
- 2017-04-19 Effective date(s) 04/07/2017
- 2017-04-19 Comp. became Pub. Ch. 112
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/1c90b52e-ae2e-433b-85a8-807236eae63d. Confidence: reported (aggregated from official Tennessee legislature records).